Cited by 250Pharmaceutical industry and healthcareEthics and bioethics in healthcareEthics in medical practice

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

All Gifts Large and Small

Open access

Katz, Dana, Caplan, Arthur L., Merz, Jon F.·2003·The American Journal of Bioethics

Open this paper in CoChat — free account Open PDF

Abstract

Much attention has been focused in recent years on the ethical acceptability of physicians receiving gifts from drug companies. Professional guidelines recognize industry gifts as a conflict of interest and establish thresholds prohibiting the exchange of large gifts while expressly allowing for the exchange of small gifts such as pens, note pads, and coffee. Considerable evidence from the social sciences suggests that gifts of negligible value can influence the behavior of the recipient in ways the recipient does not always realize. Policies and guidelines that rely on arbitrary value limits for gift-giving or receipt should be reevaluated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1162/15265160360706552

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The norm of reciprocity: A preliminary statement
Gouldner, A. W. (1960) · American Sociological Review · doi:10.2307/2092623 · Cited by 12,001
Influence: The Psychology of Persuasion
Cialdini, R. B. (1993) · Cited by 2,563
The Elementary Structures of Kinship
Lévi‐Strauss, C. (1969) · Cited by 1,501
Physicians and the Pharmaceutical Industry
Wazana, A. D. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,427
Explaining Bargaining Impasse: The Role of Self-Serving Biases
Babcock, L., & Loewenstein, G. (1997) · Journal of Economic Perspectives · doi:10.1257/jep.11.1.109 · Cited by 1,071
Scientific versus commercial sources of influence on the prescribing behavior of physicians
Avorn, J., Chen, M., & Hartley, R. M. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90911-1 · Cited by 566
The Relevance of Models for Social Anthropology.
Leach, E. R., & Banton, M. (1966) · Man · doi:10.2307/2796812 · Cited by 493
Physicians' Behavior and Their Interactions With Drug Companies
Chren, M. M. (1994) · JAMA · doi:10.1001/jama.271.9.684 · Cited by 437
Corporate Crime in the Pharmaceutical Industry
Clarke, M., & Braithwaite, J. B. (1984) · Journal of Law and Society · doi:10.2307/1410045 · Cited by 394
The Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns
Orlowski, J. P., & Wateska, L. P. (1992) · CHEST Journal · doi:10.1378/chest.102.1.270 · Cited by 386

Show all 38 references

Research works printed but not linked: 8

Coste, J. 1999. How drug promotion affects physician prescribing behaviour. eBMJ 319. www.bmj.com/cgi/content/full/319/7202/69.
Dodd, P, T. Dexter. 1999. Reasons for seeing drug reps. BMJ 319:69-70. Federal Register/Vol.67, No.192/ 3 October 2002/Notices: 62057-62067.
Jacobs, A. 1999. But doctors do see them: "freebies" seem disproportionately important. eBMJ (319):69-70. www.bmj.com/cgi/content/full/319/7202/69
Leakey, R., R. Lewin. 1978. People of the Lake. New York: Anchor Press/Doubleday.
Mauss M. 1954. The Gift. London: Routledge & Kegan Paul.
Razran, G.H.S. 1940. Conditioned response changes in rating and appraising sociopolitical slogans. Psychology Bulletin 37:481.
Review and Outlook: Green Mountain Drugs. Wall Street Journal 2002; June 20: A16:1.
Tanner, L. 2001. AMA Discourages Drug Company Gifts. The Associated Press State & Local Wire. 17 June.

Sorted by citations

Doctors and Drug Companies
Blumenthal, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmhpr042734 · Cited by 238
How pharmaceutical industry funding affects trial outcomes: Causal structures and responses
Sismondo, S. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.01.010 · Cited by 217
Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors
Blumenthal, D., Campbell, E. G., Gokhale, M., Yucel, R. M., Clarridge, B. R., Hilgartner, S., & Holtzman, N. A. (2006) · Academic Medicine · doi:10.1097/00001888-200602000-00008 · Cited by 213
A Comparison of DSM-IV and DSM-5 Panel Members' Financial Associations with Industry: A Pernicious Problem Persists
Cosgrove, L., & Krimsky, S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001190 · Cited by 234
Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry — Self-Regulation in the Shadow of Federal Prosecution
Studdert, D., Mello, M. M., & Brennan, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmlim042229 · Cited by 97
‘A pill for every ill’: Explaining the expansion in medicine use
Busfield, J. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.10.068 · Cited by 180
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement
Moynihan, R. (2003) · BMJ · doi:10.1136/bmj.326.7400.1189 · Cited by 169
Science, Policy, and the Transparency of Values
Elliott, K. C., & Resnik, D. B. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1408107 · Cited by 154
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications
Lexchin, J. (2011) · Science and Engineering Ethics · doi:10.1007/s11948-011-9265-3 · Cited by 165
Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data
Samuel, A. M., Webb, M. L., Lukasiewicz, A. M., Bohl, D. D., Basques, B. A., Russo, G. S., Rathi, V. K., & Grauer, J. N. (2015) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-015-4413-8 · Cited by 106
Disclosing and managing non-financial conflicts of interest in scientific publications
Resnik, D. B. (2023) · Research Ethics · doi:10.1177/17470161221148387 · Cited by 113
Guidelines for Interactions between Clinical Faculty and the Pharmaceutical Industry: One Medical School's Approach
COLEMAN, D. L., Kazdin, A. E., Miller, L. A., Morrow, J. S., & Udelsman, R. (2006) · Academic Medicine · doi:10.1097/00001888-200602000-00011 · Cited by 94
Taking Financial Relationships into Account When Assessing Research
Resnik, D. B., & Elliott, K. C. (2013) · Accountability in Research · doi:10.1080/08989621.2013.788383 · Cited by 94
The case for developing a cohesive systems approach to research across unhealthy commodity industries
Knai, C., Petticrew, M. P., Capewell, S., Cassidy, R., Collin, J., Cummins, S., Eastmure, E., Fafard, P., Fitzgerald, N., Gilmore, A., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-003543 · Cited by 90
Understanding Research Misconduct: A Comparative Analysis of 120 Cases of Professional Wrongdoing
DuBois, J. M., Anderson, E. E., Chibnall, J., Carroll, K., Gibb, T., Ogbuka, C., & Rubbelke, T. (2013) · Accountability in Research · doi:10.1080/08989621.2013.822248 · Cited by 81
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling
Semaan, S., Santibanez, S. S., Garfein, R. S., Heckathorn, D. D., & Jarlais, D. C. D. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.12.006 · Cited by 80
A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: Is what they tell us important and true?
Cardarelli, R., Licciardone, J. C., & Taylor, L. G. (2006) · BMC Family Practice · doi:10.1186/1471-2296-7-13 · Cited by 79
Orthopaedics and the Physician Payments Sunshine Act
Iyer, S., Derman, P. B., & Sandhu, H. S. (2016) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.o.00343 · Cited by 79
Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs
Galderisi, S., Appelbaum, P. S., Gill, N., Gooding, P., Herrman, H., Melillo, A., Myrick, K., Pathare, S., Savage, M., Szmukler, G., et al. (2024) · World Psychiatry · doi:10.1002/wps.21230 · Cited by 76
Application of a Sensemaking Approach to Ethics Training in the Physical Sciences and Engineering
Kligyte, V., Marcy, R. T., Waples, E. P., Sevier, S. T., Godfrey, E., Mumford, M. D., & Hougen, D. F. (2007) · Science and Engineering Ethics · doi:10.1007/s11948-007-9048-z · Cited by 83
You Owe Me
Malmendier, U. M., & Schmidt, K. M. (2017) · American Economic Review · doi:10.1257/aer.20140890 · Cited by 68
Medicines Information and the Regulation of the Promotion of Pharmaceuticals
Alves, T. L., Lexchin, J., & Mintzes, B. J. (2018) · Science and Engineering Ethics · doi:10.1007/s11948-018-0041-5 · Cited by 63
Attention-Deficit Hyperactivity Disorder (ADHD): Does New Research Support Old Concepts?
Furman, L. (2008) · Journal of Child Neurology · doi:10.1177/0883073808318059 · Cited by 59
Is it Really All about the Money? Reconsidering Non-Financial Interests in Medical Research
Saver, R. S. (2012) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2012.00679.x · Cited by 62
The ethics of pharmaceutical industry relationships with medical students
Rogers, W., Mansfield, P. R., Braunack‐Mayer, A., & Jureidini, J. N. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05995.x · Cited by 58
Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia
McNeill, P. M., Kerridge, I., Henry, D. A., Stokes, B., Hill, S. R., Newby, D., Macdonald, G. J., Day, R. O., Maguire, J. M., & Henderson, K. M. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01151.x · Cited by 46
Does Conflict of Interest Disclosure Worsen Bias?
Editors, T. P. M. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001210 · Cited by 46
The Hidden Curriculum: Medical Students’ Changing Opinions toward the Pharmaceutical Industry
Fitz, M. M., Homan, D. J., Reddy, S. T., Griffith, C. H., Baker, E. A., & Simpson, K. P. (2007) · Academic Medicine · doi:10.1097/acm.0b013e31813e7f02 · Cited by 44
Attitudes and Relationship between Physicians and the Pharmaceutical Industry in a Public General Hospital in Lima, Peru
Ferrari, A. D., Sanchez, C. G., Davalos, L., Huayanay, L., & Málaga, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100114 · Cited by 44
The High Cost of Free Lunch
Wall, L. L., & Brown, D. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000268800.46677.14 · Cited by 43
New Federal Guidelines For Physician–Pharmaceutical Industry Relations: The Politics Of Policy Formation
Chimonas, S. C., & Rothman, D. J. (2005) · Health Affairs · doi:10.1377/hlthaff.24.4.949 · Cited by 43
Has the hunt for conflicts of interest gone too far? Yes
Stossel, T. P. (2008) · BMJ · doi:10.1136/bmj.39493.489213.ad · Cited by 43
Debunking Myths in Physician–Industry Conflicts of Interest
Lichter, P. R. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.04.007 · Cited by 42
In Defence of Consideration
Chen-Wishart, M. (2013) · Oxford University Commonwealth Law Journal · doi:10.5235/14729342.13.1.209 · Cited by 40
‘If someone donates $1000, they support you. If they donate $100 000, they have bought you’. Mixed methods study of tobacco, alcohol and gambling industry donations to Australian political parties
Kypri, K., McCambridge, J., Robertson, N., Martino, F. P., Daube, M., Adams, P. J., & Miller, P. G. (2018) · Drug and Alcohol Review · doi:10.1111/dar.12878 · Cited by 40
Pharmaceutical Industry Marketing: Understanding Its Impact on Women’s Health
Sufrin, C., & Ross, J. S. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31817f1585 · Cited by 39
Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia
Doran, E., Kerridge, I., McNeill, P. M., & Henry, D. A. (2005) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.07.037 · Cited by 38
A survey of pharmaceutical company representative interactions with doctors in Libya
Alssageer, M. A., & Kowalski, S. R. (2012) · Libyan Journal of Medicine · doi:10.3402/ljm.v7i0.18556 · Cited by 37
Conflict of Interest in Clinical Practice
Tonelli, M. R. (2007) · CHEST Journal · doi:10.1378/chest.07-0315 · Cited by 37
Institutional Leadership and Faculty Response: Fostering Professionalism at the University of Pennsylvania School of Medicine
Wasserstein, A. G., Brennan, P. J., & Rubenstein, A. H. (2007) · Academic Medicine · doi:10.1097/acm.0b013e31815763d2 · Cited by 36
Ethical issues in the pharmaceutical industry: an analysis of US newspapers
Sillup, G. P., & Porth, S. J. (2008) · International Journal of Pharmaceutical and Healthcare Marketing · doi:10.1108/17506120810903953 · Cited by 35
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
Robertson, J., Moynihan, R. N., Walkom, E. J., Bero, L. A., & Henry, D. A. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000128 · Cited by 34
McCarthyism, conflict of interest andAddiction's new transparency declaration procedures
Babor, T. F., & Miller, P. G. (2014) · Addiction · doi:10.1111/add.12384 · Cited by 33
Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: The undiscovered country
Crigger, N. (2005) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1041-2972.2005.00034.x · Cited by 33
Ethics and science: an introduction
(2013) · Choice Reviews Online · doi:10.5860/choice.50-4958 · Cited by 31
Undisclosed financial conflicts of interest in DSM-5-TR: cross sectional analysis
Davis, L. C., Diianni, A. T., Drumheller, S. R., Elansary, N. N., D’Ambrozio, G., Herrawi, F., Piper, B. J., & Cosgrove, L. (2024) · BMJ · doi:10.1136/bmj-2023-076902 · Cited by 33
The Medical–Industrial Complex, Professional Medical Associations, and Continuing Medical Education
Schofferman, J. A. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01282.x · Cited by 30
Concussions, Professional Sports, and Conflicts of Interest: Why the National Football League’s Current Policies are Bad for Its (Players’) Health
Goldberg, D. S. (2008) · HEC Forum · doi:10.1007/s10730-008-9079-0 · Cited by 27
Financial and intellectual conflicts of interest: confusion and clarity
Bion, J. (2009) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328332f53a · Cited by 29
Hidden Persuaders: Do Small Gifts Lubricate Business Negotiations?
Maréchal, M. A., & Thöni, C. (2018) · Management Science · doi:10.1287/mnsc.2018.3113 · Cited by 29
A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India
Gupta, S. K., Nayak, R., & Sivaranjani, R. (2015) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.171695 · Cited by 27
Factors That Influence Physicians' Prescribing of Pharmaceuticals: A Literature Review
Gallan, A. S. (2004) · Journal of Pharmaceutical Marketing & Management · doi:10.3109/j058v16n04_02 · Cited by 27
Symposium
Jacobs, J. J., Galante, J. O., Mirza, S. K., & Zdeblick, T. A. (2006) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.e.01049 · Cited by 27
Braving a faceless new world? Conceptualizing trust in the pharmaceutical industry and its products
Brown, P. R., & Calnan, M. (2010) · Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine · doi:10.1177/1363459309360783 · Cited by 26
Should we welcome food industry funding of public health research?
Aveyard, P. N., Yach, D., Gilmore, A., & Capewell, S. (2016) · BMJ · doi:10.1136/bmj.i2161 · Cited by 26
A systematic review of the influence of medical representatives and promotional tools on prescribing
Murshid, M. A., & Mohaidin, Z. (2017) · International Journal of Pharmaceutical and Healthcare Marketing · doi:10.1108/ijphm-09-2016-0047 · Cited by 25
Attitudes of physicians and public to pharmaceutical industry ‘gifts’
Macneill, P. U., Kerridge, I., Newby, D., Stokes, B., Doran, E., & Henry, D. A. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02233.x · Cited by 25
Should journals publish industry-funded bioethics articles?
Elliott, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66794-3 · Cited by 23
The Price of Collaboration: How Authoritarian States Retain Control
Piotrowska, B. M. (2020) · Comparative Political Studies · doi:10.1177/0010414020912277 · Cited by 22
Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty
Hollander, M. A. G., Donohue, J. M., Stein, B. D., Krans, E. E., & Jarlenski, M. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05470-0 · Cited by 22
Dishonesty in medicine revisited.
Fred, H. L. (2008) · PubMed Central · Cited by 22
Pharmacists and Industry: Guidelines for Ethical Interactions
American College of Clinical Pharmacy (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.3.410 · Cited by 21
Managing the Risks of Corporate Political Donations: A Utilitarian Perspective
Leong, S., Hazelton, J., & Townley, C. (2012) · Journal of Business Ethics · doi:10.1007/s10551-012-1592-z · Cited by 21
Conflict of interest and professional medical associations: the North American Spine Society experience
Schofferman, J. A., Eskay-Auerbach, M., Sawyer, L. S., Herring, S. A., Arnold, P. M., & Muehlbauer, E. J. (2012) · The Spine Journal · doi:10.1016/j.spinee.2012.08.019 · Cited by 20
Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors
Edwards, D., & Ballantyne, A. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01887.x · Cited by 20
Industry Support of Graduate Medical Education in Surgery
Nakayama, D. K., & Bozeman, A. P. (2009) · The American Surgeon · doi:10.1177/000313480907500509 · Cited by 20
A Social Epistemological Inquiry into Biases in Journal Peer Review
Jukola, S. (2016) · Perspectives on Science · doi:10.1162/posc_a_00237 · Cited by 19
Pharmaceutical industry and the market: The case of Prozac and other antidepressants
Das, A. (2011) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2011.01.002 · Cited by 20
Can a good tree bring forth evil fruit? The funding of medical research by industry
Capps, B. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw014 · Cited by 19
Food for thought? Potential conflicts of interest in academic experts advising government and charities on dietary policies
Newton, A., Lloyd‐Williams, F., Bromley, H., & Capewell, S. (2016) · BMC Public Health · doi:10.1186/s12889-016-3393-2 · Cited by 19
Mental health nursing students’ relationships with the pharmaceutical industry
Ashmore, R., Carver, N., & Banks, D. (2006) · Nurse Education Today · doi:10.1016/j.nedt.2006.08.016 · Cited by 19
International Breastfeeding Initiatives and their Relevance to the Current State of Breastfeeding in the United States
Walker, M. (2007) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2007.06.013 · Cited by 19
Conflicts of interest in pain medicine: Practice patterns and relationships with industry
Schofferman, J. A., & Banja, J. D. (2008) · Pain · doi:10.1016/j.pain.2008.08.016 · Cited by 19
Containing Global Antibiotic Resistance: Ethical Drug Promotion in the Developing World
Olivier, C., Williams–Jones, B., Martineau‐Doizé, B., & Özdemir, V. (2009) · Springer eBooks · doi:10.1007/978-0-387-89370-9_29 · Cited by 18
Politely refuse the pen and note pad: gifts from industry to physicians harm patients.
Iserson, K., Cerfolio, R., & Sade, R. (2007) · Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.06.032 · Cited by 13
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences
Roussel, Y., & Raoult, D. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100710 · Cited by 17
A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding
Ozierański, P., Pitter, J. G., Rickard, E., Mulinari, S., & Csanádi, M. (2021) · Sociology of Health & Illness · doi:10.1111/1467-9566.13409 · Cited by 16
Perception of Prescription Medicine Sample Packs Among Australian Professional, Government, Industry, and Consumer Organizations, Based on Automated Textual Analysis of One-on-One Interviews
Kyle, G. J., Nissen, L. M., & Tett, S. E. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.016 · Cited by 16
Conflict of Interest in the Physician Interface with the Biomedical Industry
Minnigan, H. J., & Chisholm, C. D. (2006) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2006.05.008 · Cited by 16
Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines
Kyle, G. J., Nissen, L. M., & Tett, S. E. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00948.x · Cited by 16
Conflicts of Interest: can a physician serve two masters?
Greenberg, R. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.06.003 · Cited by 15
Gifts to Physicians From Industry: The Debate Evolves
Moskop, J. C., Iserson, K. V., Aswegan, A. L., Larkin, G. L., & Schears, R. M. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.08.001 · Cited by 15
Scientific integrity, fidelity and conflicts of interest in research
Warner, T. D., & Roberts, L. W. (2004) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000139974.45189.96 · Cited by 15
The Ethics of Stem Cell-Based Aesthetic Surgery: Attitudes and Perceptions of the Plastic Surgery Community
Nayar, H. S., Caplan, A. L., Eaves, F. F., & Rubin, J. P. (2014) · Aesthetic Surgery Journal · doi:10.1177/1090820x14539971 · Cited by 15
Self-citation
What patients think about promotional activities of pharmaceutical companies in Turkey
Şemin, S., Güldal, D., Özçakar, N., & Mevsim, V. (2006) · Pharmacy World & Science · doi:10.1007/s11096-006-9032-8 · Cited by 15
Response to Open Peer Commentaries on “The Pitfalls of Deducing Ethics from Economics: Why the Association of American Medical Colleges is Wrong About Pharmaceutical Detailing”
Huddle, T. S. (2010) · The American Journal of Bioethics · doi:10.1080/15265160903493088 · Cited by 15
The prevention and detection of corruption in pharmaceutical companies
Peltier‐Rivest, D. (2017) · Pharmaceuticals Policy and Law · doi:10.3233/ppl-170451 · Cited by 14
Addressing problems in profit-driven research: how can feminist conceptions of objectivity help?
Intemann, K. K., & de Melo‐Martín, I. (2014) · European Journal for Philosophy of Science · doi:10.1007/s13194-013-0079-9 · Cited by 19
Conflicts of interest in psychiatry: Strategies to cultivate literacy in daily practice
Shimazawa, R., & Ikeda, M. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12201 · Cited by 14
Gifts-Upon-Entry and Appreciatory Comments: Reciprocity Effects in Retailing
Friedman, H. H., & Rahman, A. (2011) · International Journal of Marketing Studies · doi:10.5539/ijms.v3n3p161 · Cited by 14
The Commercialization of Research and the Quest for the Objectivity of Science
Jukola, S. (2014) · Foundations of Science · doi:10.1007/s10699-014-9377-8 · Cited by 17
Dialectical Interactions: Decoupling and Integrating Ethics in Ethics Initiatives
Jovanovic, S., & Wood, R. V. (2007) · Business Ethics Quarterly · doi:10.5840/beq200717227 · Cited by 13
The Pitfalls of Deducing Ethics From Behavioral Economics: Why the Association of American Medical Colleges Is Wrong About Pharmaceutical Detailing
Huddle, T. S. (2010) · The American Journal of Bioethics · doi:10.1080/15265160903440998 · Cited by 14
Pharmaceutical Industry discursives and the marketization of nursing work: a case example
Springer, R. A. (2011) · Nursing Philosophy · doi:10.1111/j.1466-769x.2011.00498.x · Cited by 13
Assessment of self-reported financial conflicts of interest in vascular surgery studies
Tian, T. M., Shah, A. Y., Darling, J. D., Zaepfel, C., Chatterjee, A., Iafrati, M. D., & Salehi, P. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.05.040 · Cited by 13
Health Care Clinicians and Product Promotion by Industry
Diekema, D. S., Macauley, R., Basak, R., Geis, G. M., Laventhal, N. T., Opel, D. J., & Statter, M. B. (2022) · PEDIATRICS · doi:10.1542/peds.2022-056549 · Cited by 13
Understanding Physician-Pharmaceutical Industry Interactions: A Concise Guide
Jain, S. (2007) · Cited by 13
Pharmacists, pharmaceutical manufacturers, and conflicts of interest
Banks, D. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040504 · Cited by 13
Inadequate conflict of interest policies at most French teaching hospitals: A survey and website analysis
Guy-Coichard, C., Perraud, G., Chailleu, A., Gaillac, V., Scheffer, P., & Mintzes, B. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224193 · Cited by 12
Association Between Open Payments–Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US
Nguyen, A. M., Anderson, K. E., Anderson, G. F., & Johnson, T. V. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.2757 · Cited by 12

Authors: Katz, D., Caplan, A. L., & Merz, J. F.
Affiliations: University of Pennsylvania (US)
ORCID: Caplan, Arthur L.
Merz, Jon F.
Venue: The American Journal of Bioethics
Publisher: Informa UK Limited
Published: 2003-08
Volume: 3
Issue: 3
Pages: 39-46
ISSN: 1526-5161 (ISSN-L)
1536-0075
DOI: 10.1162/15265160360706552
OpenAlex: W2093947703
Cited by: 250
References: 38
Citations by year: 2026: 2 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 18 · 2020: 5 · 2019: 8 · 2018: 12 · 2017: 8 · 2016: 13 · 2015: 10 · 2014: 15 · 2013: 10 · 2012: 17
FWCI: 9.87
Type: journal article
Language: en
Open access: green
repository.upenn.edu
Locations: The American Journal of Bioethics (publishedVersion)
PubMed (publishedVersion)
ScholarlyCommons (University of Pennsylvania) (submittedVersion)
Funders: Pfizer
University of Pennsylvania
Topics: Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
Health Sciences › Health Professions › General Health Professions › Ethics in medical practice
Keywords: physician gifts, pharmaceutical industry, conflicts of interest, physician-industry relations, physician professionalism, moral norms
MeSH terms: American Medical Association, Drug Industry, Humans, Interpersonal Relations, Marketing of Health Services, Practice Patterns, Physicians', Physicians, Social Behavior, Social Control, Formal, United States, Conflict of Interest, Disclosure, Gift Giving

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

All Gifts Large and Small

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks